Cargando…
The journey from gene knockout to clinical medicine: telotristat and sotagliflozin
Gene knockout has been a powerful technique to evaluate the physiologic role of selected gene products. Lexicon pioneered high-throughput gene knockout technology and went further in designing agents to inhibit products of gene expression. Two agents have entered late-stage development. Telotristat...
Autor principal: | Rendell, Marc S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408923/ https://www.ncbi.nlm.nih.gov/pubmed/30880915 http://dx.doi.org/10.2147/DDDT.S144556 |
Ejemplares similares
-
Developments in the treatment of carcinoid syndrome – impact of telotristat
por: Chan, David L, et al.
Publicado: (2018) -
Telotristat ethyl for carcinoid syndrome diarrhoea
Publicado: (2019) -
Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome
por: Metz, David C, et al.
Publicado: (2020) -
A review of sotagliflozin for use in type 1 diabetes
por: Nuffer, Wesley, et al.
Publicado: (2019) -
Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives
por: Cefalo, Chiara Maria Assunta, et al.
Publicado: (2019)